Your browser doesn't support javascript.
loading
Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-ß1 Mediated Epithelial-to-Mesenchymal Transition.
Li, Deyu; Tong, Qin; Lian, Yuane; Chen, Zhizhong; Zhu, Yaru; Huang, Weimei; Wen, Yang; Wang, Qiongyao; Liang, Shumei; Li, Man; Zheng, Jianjing; Liu, Zhenhua; Liu, Huanxin; Guo, Linlang.
Afiliação
  • Li D; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Tong Q; Department of Medical Oncology, Provincial Clinical College, Fujian Medical University, Fujian provincial hospital, Fuzhou, China.
  • Lian Y; Department of Radiation Oncology, The First Affiliated Hospital of University of South China, Hengyang, China.
  • Chen Z; Department of Pathology, The Union Hospital of Fujian Medical University, Fuzhou, China.
  • Zhu Y; Department of Pathology, Provincial Clinical College, Fujian Medical University, Fujian provincial hospital, Fuzhou, China.
  • Huang W; Department of Cardiothoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wen Y; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wang Q; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Liang S; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Li M; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Zheng J; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Liu Z; Department of Medical Oncology, Provincial Clinical College, Fujian Medical University, Fujian provincial hospital, Fuzhou, China.
  • Liu H; Department of Medical Oncology, Provincial Clinical College, Fujian Medical University, Fujian provincial hospital, Fuzhou, China.
  • Guo L; Guangdong Provincial Corps Hospital of Chinese People's Armed Police Forces, Guangzhou Medical University, Guangzhou, China.
Cancer Res Treat ; 53(4): 1042-1056, 2021 Oct.
Article em En | MEDLINE | ID: mdl-33705625
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Fator de Crescimento Transformador beta1 / Carcinoma de Pequenas Células do Pulmão / Transição Epitelial-Mesenquimal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação:
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Fator de Crescimento Transformador beta1 / Carcinoma de Pequenas Células do Pulmão / Transição Epitelial-Mesenquimal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: